Parts of North Carolina are implementing water use restrictions amid ongoing drought conditions. Charlotte and Raleigh are two of the localities affected. Ilhan Omar's husband's winery terminated ...

Novo Nordisk is gearing up to submit its rare blood disorder drug to the FDA after the former Forma Therapeutics asset reduced a painful complication of sickle cell disease (SCD) in a phase 3 study.

The water restrictions taking effect Monday in Raleigh are expected to last more than a month, according to a city spokesperson. City of Raleigh environmental coordinator Ed Buchan estimated that the ...

Not too long ago I would have said I was one of the least likely people to be tempted by GLP-1s like Wegovy or Zepbound. My weight has always been average. I have no medical conditions, and more than ...

Denver Board of Water Commissioners adopted a resolution approving the implementation of temporary drought pricing at a meeting Wednesday. Denver Water said that the drought pricing will apply ...

Employer cost coverage increases likelihood of GLP-1 use (65% overall), peaking in ages 35–44 (75%) and declining sharply among workers ≥65 (37%). Behavioral support programs shift willingness to self ...

The World Anti-Doping Agency (WADA) said it is now monitoring GLP-1 use among elite athletes, including at the Winter Olympics in Italy. Being ‘monitored’ does not mean a substance is prohibited; ...

A box blade can handle leveling, grading, and cleanup jobs that make it one of the most useful first tools to own. It is the kind of implement that quickly proves its value the moment real work starts ...

Basalt will be implementing Stage 1 water restrictions starting Wednesday, April 1, to reduce water consumption. The town’s municipal code gives them the ability to enable water restrictions between ...

Corebridge Financial and Equitable Holdings have agreed to an all-stock merger valued at approximately $22 billion that will create a life insurance, annuity, wealth and asset management company ...

For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses. About one in every eight U.S. adults is currently taking a ...

A large VHA real-world analysis compared GLP‑1 receptor agonists (~132,000) with sulfonylureas (>201,000), focusing on major adverse cardiovascular outcomes in type 2 diabetes. Continuous GLP‑1 ...